Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The letter

Surprisingly, considering your obvious lack of intellect in supporting those despicable cheater-coached and bastard-child-fathering QB'd NE Pansidiots, your post has brought up an excellent point that can be added to the shareholder letter list of questions.  That is:

 

Considering the positive Markman results, and the settlemet of the litigation in Texas, are the "early mover" discounts a thing of the past, and are and will future licensses be subjected to higher licesnse fees that those licenses prior to the settlements?  Can you generally qualify what "higher" fees represent, ie. does that mean 25% premium, 50% premium, etc.?

Share
New Message
Please login to post a reply